Prostaglandin F2 receptor negative regulator as a potential target for chimeric antigen receptor-T cell therapy for glioblastoma

Hideki Kuroda(The University of Osaka), Haruhiko Kishima(Osaka University Hospital)
Cancer Immunology Immunotherapy
March 6, 2025
Cited by 1


Related Papers